Tables
- TABLE 1
Patient characteristics of the COVID-19 home monitoring cohort
Total cohort (n=320) Readmitted patients (n=23) Gender Male 206 (64) 17 (74) Age, years 56±12 62±10 COVID-19 diagnosis based on PCR 318 (99) 23 (100) Computed tomography 1 (0.3) 0 Chest radiograph 1 (0.3) 0 Underlying comorbidities Diabetes mellitus 39 (12) 4 (17) Hypertension 89 (28) 10 (43) Obesity (BMI >30 kg·m−2) 100 (31) 3 (13) Chronic pulmonary disease 90 (28) 11 (48) Chronic heart disease 54 (17) 11 (48) Immunocompromised state 10 (3) 1 (4) Admission to intensive care unit 54 (17) 1 (4) Length of stay on intensive care unit, days 9±8.5 5 Oxygen therapy during hospitalisation Nasal oxygen or non-rebreather mask 260 (82) 21 (91) Non-invasive ventilation or nasal high flow oxygen therapy 45 (14) 2 (9) Intubation 11 (3.4) 0 Duration of disease on admission to home monitoring, days 18±9.1 15.6±10.5 Length of hospitalisation, days 8.6±6.6 6.8±5.2 Fever at time of discharge 7 (2) 2 (9) Oxygen therapy when discharged Yes 196 (61) 16 (70) No 124 (39) 7 (30) Total reduction in length of hospitalisation, days In need for oxygen therapy (n=189)# 1200 No need for oxygen therapy (n=76)¶ 141.5 Mean reduction in length of stay, days (n=265) 5.1±3.4 Length of home monitoring, days 11.7±5.4 Number of telephone contacts 5.7±3.0 Normally distributed data are presented as mean±sd; categorical data are presented as n (%). BMI: body mass index. #: seven patients were excluded due to re-admission or follow up in another hospital; ¶: in 31 patients, no reduction in length of stay was noted; in 17 patients, no reduction in length of stay was expected.
Supplementary Materials
Supplementary Material
This one-page PDF can be shared freely online.
Shareable PDF ERJ-01871-2021.Shareable
Vol 58 Issue 5
Table of Contents
Home-monitoring reduces hospital stay for COVID-19 patients
